Literature DB >> 18301024

Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation.

K Bailey Freund1, I-Van Ho, Irene A Barbazetto, Hideki Koizumi, Ketan Laud, Daniela Ferrara, Yoko Matsumoto, John A Sorenson, Lawrence Yannuzzi.   

Abstract

BACKGROUND: Retinal angiomatous proliferation (RAP) is a distinct form of neovascularization in patients with age-related macular degeneration. Lacking definitive sequential histopathologic evidence of its intraretinal versus choroidal origin, the clinical observations of early stages of RAP lesions may provide clues to help further expand our understanding of this entity.
METHODS: Five eyes of four patients with early Stage 1 RAP were examined. Fundus photography, fluorescein and indocyanine green angiography as well as time-domain and spectral-domain optical coherence tomography were performed. Images were assessed to determine the characteristics of neovascularization in early stage RAP lesions and the response of the lesions to treatment or observation.
RESULTS: The analysis of the selected cases suggests a choroidal origin of the neovascular complex with the early formation of a retinal choroidal anastomosis without evidence of underlying occult Type 1 neovascularization. Three eyes responded to a single treatment with intravitreal ranibizumab (0.5 mg) and 2 eyes (1 patient) resolved spontaneously without treatment.
CONCLUSION: The neovascularization in RAP may originate not only from deep retinal capillaries but also from the choroid. We therefore propose the more descriptive term "Type 3 neovascularization" for this entity to emphasize the intraretinal location of the vascular complex and distinguish this type from the two types of neovascularization previously described by J. Donald Gass in his classic text.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18301024     DOI: 10.1097/IAE.0b013e3181669504

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  59 in total

1.  Assessing the long-term evolution of type 3 neovascularization in age-related macular degeneration using optical coherence tomography angiography.

Authors:  Han Joo Cho; Soo Hyun Lim; Jaemin Kim; Jihyun Lee; Dong Won Lee; Jong Woo Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-03-21       Impact factor: 3.117

Review 2.  The stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocity.

Authors:  D Kent
Journal:  Eye (Lond)       Date:  2015-07-31       Impact factor: 3.775

3.  Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration.

Authors:  Cheolmin Yun; Jaeryung Oh; Jaemoon Ahn; Soon-Young Hwang; Boram Lee; Seong-Woo Kim; Kuhl Huh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-19       Impact factor: 3.117

4.  [Forms of age-related macular degeneration].

Authors:  M Schargus
Journal:  Ophthalmologe       Date:  2015-04       Impact factor: 1.059

5.  CLINICOPATHOLOGIC CORRELATION OF RETINAL ANGIOMATOUS PROLIFERATION TREATED WITH RANIBIZUMAB.

Authors:  Alison H Skalet; Audra K Miller; Michael L Klein; Andreas K Lauer; David J Wilson
Journal:  Retina       Date:  2017-08       Impact factor: 4.256

6.  Ranibizumab for retinal angiomatous proliferation.

Authors:  Alexandros A Rouvas; Thanos D Papakostas; Ioannis D Ladas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-09       Impact factor: 3.117

7.  Three dimensional spectral domain optical coherence tomography features of retinal-choroidal anastomosis.

Authors:  Giuseppe Querques; Fernando O Avellis; Lea Querques; Nathalie Massamba; Francesco Bandello; Eric H Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-23       Impact factor: 3.117

8.  [Fluorescein, indocyanine green and optical coherence tomography angiography in patients with native exudative age-related macular degeneration].

Authors:  L J B Pauleikhoff; K Blobner; K Wehrmann; N Feucht; C P Lohmann; M Maier
Journal:  Ophthalmologe       Date:  2018-07       Impact factor: 1.059

9.  Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation.

Authors:  Han Joo Cho; Tae Gon Lee; Sang Youn Han; Hyoung Seok Kim; Jae Hui Kim; Jung Il Han; Young Ju Lew; Jong Woo Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-01       Impact factor: 3.117

10.  Two-year results of combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.

Authors:  Masaaki Saito; Tomohiro Iida; Mariko Kano; Kanako Itagaki
Journal:  Jpn J Ophthalmol       Date:  2016-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.